CME/CE: Managing Adult Respiratory Syncytial Virus

CME/CE: Managing Adult Respiratory Syncytial Virus
Author Information (click to view)

Lindsay Kim, MD, MPH

Medical Epidemiologist, Division of Viral Diseases
Centers for Disease Control and Prevention

Lindsay Kim, MD, MPH, has indicated to Physician’s Weekly that she has no financial disclosures to report.

+


Lindsay Kim, MD, MPH (click to view)

Lindsay Kim, MD, MPH

Medical Epidemiologist, Division of Viral Diseases
Centers for Disease Control and Prevention

Lindsay Kim, MD, MPH, has indicated to Physician’s Weekly that she has no financial disclosures to report.

While it is often thought of as a disease in children, respiratory syncytial virus (RSV) infections cause significant illness and death in older adults every year. Clinicians are urged to learn more about the illness and death caused by RSV in these patients and to develop protocols in anticipation of vaccinations against the virus.
Share on FacebookTweet about this on TwitterShare on LinkedIn
Readings & Resources (click to view)

CDC. Respiratory syncytial virus (RSV) infection. For Healthcare Professionals. Available at: https://www.cdc.gov/rsv/clinical/index.html.

McClure DL, Kieke BA, Sundaram ME, et al. Seasonal incidence of medically attended respiratory syncytial virus infection in a community cohort of adults ≥50 years old. See comment in PubMed Commons belowPLoS One. 2014;9:e102586. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25025344.

Higgins D, Trujillo C, Keech C. Advances in RSV vaccine research and development – a global agenda. Vaccine. 2016;34:2870-2875. Available at: http://www.sciencedirect.com/science/article/pii/S0264410X16301682.

Falsey AR, Hennessey RN, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. New Engl J Med. 2005;352:1749-1759.

Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13:371-384.

Mayo Clinic. Diseases and Conditions. Respiratory syncytial virus (RSV). Available at: http://www.mayoclinic.org/diseases-conditions/respiratory-syncytial-virus/basics/symptoms/con-20022497.

Simões EAF, DeVincenzo JP, Boeckh M, et al. Challenges and opportunities in developing respiratory syncytial virus therapeutics. J Infect Dis. 2015;211(suppl 1):S1-S20.

Branche AR, Falsey AR. Respiratory syncytial virus infection in older adults: an under-recognized problem. Drugs Aging. 2015;32:261-269.

Fleming DM, Taylor RJ, Lustig RL, et al. Modelling estimates of the burden of respiratory syncytial virus infection in adults and the elderly in the United Kingdom. BMC Infect Dis. 2015;15:443-455.

Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206:56-62.

Brendish NJ, Schiff HF, Clark TW. Point-of-care testing for respiratory viruses in adults: the current landscape and future potential. J Infect. 2015;71:501-510.

Falsey AR. Respiratory syncytial virus: a global pathogen in an aging world. Clin Infect Dis. 2013;57:1078-1080.

Submit a Comment

Your email address will not be published. Required fields are marked *

2 × 5 =